Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.91 is 43% below its 5-year average of 6.91, near the low end of its 5-year range (3.91–18.32).
As of the fiscal period ended Tuesday, June 30, 2026. 7.18% below its 12-month average of 4.21.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.91.
QUICK RATIO (ACID-TEST)
3.91
QUICK RATIO (ACID-TEST) AVG TTM
4.21
QUICK RATIO (ACID-TEST) AVG 3Y
4.96
QUICK RATIO (ACID-TEST) AVG 5Y
6.91
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-7.18%
CURRENT VS 3Y AVG
-21.27%
CURRENT VS 5Y AVG
-43.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 755 covered companies
CURRENT VS SECTOR MEDIAN
+22.04%
vs the sector median at left
NeuroPace, Inc.
Market Cap
$446.12M
Quick Ratio (Acid-Test)
3.91
TTM Avg
4.21
3Y Avg
4.96
5Y Avg
6.91
Market Cap
$445.14M
Quick Ratio (Acid-Test)
12.39
TTM Avg
8.12
3Y Avg
11.14
5Y Avg
10.14
Market Cap
$449.00M
Quick Ratio (Acid-Test)
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
Market Cap
$440.34M
Quick Ratio (Acid-Test)
13.99
TTM Avg
3.82
3Y Avg
4.27
5Y Avg
5.98
Market Cap
$439.96M
Quick Ratio (Acid-Test)
7.35
TTM Avg
8.39
3Y Avg
5.06
5Y Avg
6.73
Market Cap
$435.06M
Quick Ratio (Acid-Test)
3.19
TTM Avg
3.65
3Y Avg
4.66
5Y Avg
6.11
Market Cap
$431.16M
Quick Ratio (Acid-Test)
3.35
TTM Avg
2.92
3Y Avg
4.56
5Y Avg
5.25
Market Cap
$468.47M
Quick Ratio (Acid-Test)
4.67
TTM Avg
9.07
3Y Avg
10.56
5Y Avg
11.63
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroPace, Inc. (NPCE) | $446.12M | 3.91 | 4.21 | 4.96 | 6.91 |
| Ovid Therapeutics Inc. (OVID)vs › | $445.14M | 12.39 | 8.12 | 11.14 | 10.14 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $449.00M | 6.72 | 10.04 | 13.74 | 16.43 |
| Assembly Biosciences, Inc. (ASMB)vs › | $440.34M | 13.99 | 3.82 | 4.27 | 5.98 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $439.96M | 7.35 | 8.39 | 5.06 | 6.73 |
| Editas Medicine, Inc. (EDIT)vs › | $435.06M | 3.19 | 3.65 | 4.66 | 6.11 |
| NeoGenomics, Inc. (NEO)vs › | $431.16M | 3.35 | 2.92 | 4.56 | 5.25 |
| NRC Health (NRC)vs › | $462.12M | 0.65 | 0.55 | 0.77 | 1.10 |
| Sight Sciences, Inc. (SGHT)vs › | $468.47M | 4.67 | 9.07 | 10.56 | 11.63 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $469.98M | 121.97 | 23.71 | 19.95 | 19.50 |
Quick Ratio
3.91
Excludes inventory
Current Ratio
4.94
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.91 |
| 2026-03-31 | 4.35 |
| 2025-12-31 | 4.33 |
| 2025-09-30 | 3.94 |
| 2025-06-30 | 4.51 |
| 2025-03-31 | 5.70 |
| 2024-12-31 | 4.48 |
| 2024-09-30 | 4.77 |
| 2024-06-30 | 5.47 |
| 2024-03-31 | 5.56 |
| 2023-12-31 | 5.02 |
| 2023-09-30 | 5.79 |
| 2023-06-30 | 6.65 |
| 2023-03-31 | 8.04 |
| 2022-12-31 | 8.02 |
| 2022-09-30 | 10.17 |
| 2022-06-30 | 9.13 |
| 2022-03-31 | 9.48 |
| 2021-12-31 | 13.44 |
| 2021-09-30 | 15.37 |
| 2021-06-30 | 18.32 |
| 2021-03-31 | 3.71 |
| 2020-12-31 | 4.97 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
